Traditional prognostic factors include tumor size, number of positive lymph nodes, tumor grade, and molecular biomarkers such as estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and Ki67 [1]. This evidence concerns the gene ERBB2 and neoplasm.